Researchers have been excited about Retatrutide , a novel dual agonist showing promising outcomes in early trials for weight loss . It works by modulating two pathways : GLP-1 and GIP, these, when https://deannaacgo206594.dsiblogger.com/73831415/the-new-possibility-for-body-loss